Ughi, Giovanni J. http://orcid.org/0000-0003-3354-0698
Marosfoi, Miklos G. http://orcid.org/0000-0001-8202-1603
King, Robert M. http://orcid.org/0000-0002-5144-9110
Caroff, Jildaz http://orcid.org/0000-0002-0029-1835
Peterson, Lindsy M.
Duncan, Benjamin H. http://orcid.org/0000-0003-4227-7115
Langan, Erin T.
Collins, Amanda http://orcid.org/0000-0002-4653-7095
Leporati, Anita
Rousselle, Serge
Lopes, Demetrius K. http://orcid.org/0000-0002-6280-0113
Gounis, Matthew J. http://orcid.org/0000-0002-8034-2785
Puri, Ajit S.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R43 NS100163, R44 NS100163, R43 NS100163, R44 NS100163)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke
Article History
Received: 26 November 2019
Accepted: 9 July 2020
First Online: 31 July 2020
Competing interests
: G.J.U., L.M.P., and B.H.D. are employees of Gentuity LLC and hold stocks. M.G.M. is a consultant on a fee-per-hour basis for InNeuroCo In and Stryker Neurovascular. D.K.L. has received research support from Medtronic Neurovascular. M.J.G. has received research support from the National Institutes of Health (NIH), the United States–Israel Binational Science Foundation, Anaconda, Apic Bio, Arsenal Medical, Axovant, Cerenovus, Ceretrieve, Cook Medical, Galaxy LLC, Gentuity, Imperative Care, InNeuroCo, Insera, Magneto, Microvention, Medtronic Neurovascular, MIVI Neurosciences, Neuravi, Neurogami, Philips Healthcare, Progressive Neuro, Rapid Medical, Route 92 Medical, Stryker Neurovascular, Syntheon, and the Wyss Institute; is a consultant on a fee-per-hour basis for Cerenovus, Imperative Care, Medtronic Neurovascular, Mivi Neurosciences, Phenox, Route 92 Medical, and Stryker Neurovascular; holds stock in Imperative Care, InNeuroCo, and Neurogami. A.S.P. has been a proctor on a fee-per-hour basis for Stryker Neurovascular, and Cerenovus; has research grants from Cerenovus, Medtronic Neurovascular, and Stryker Neurovascular; holds stock in InNeuroCo, and NTI. The remaining authors declare no competing interests.